Publicaciones en las que colabora con Jose Rivera Pozo (37)

2021

  1. The pi3kδ inhibitor idelalisib diminishes platelet function and shows antithrombotic potential

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

2009

  1. Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause

    British Journal of Haematology, Vol. 146, Núm. 1, pp. 95-103

2007

  1. Latent and polymeric antithrombin: Clearance and potential thrombotic risk

    Experimental Biology and Medicine, Vol. 232, Núm. 2, pp. 219-226

  2. The association of the β1-tubulin Q43P polymorphism with intracerebral hemorrhage in men

    Haematologica, Vol. 92, Núm. 4, pp. 513-518

2005

  1. Biological assessment of aspirin efficacy on healthy individuals: Heterogeneous response or aspirin failure?

    Stroke, Vol. 36, Núm. 2, pp. 276-280

2004

  1. Genetic variants of the extra-large stimulatory Gs protein alpha-subunit and risk of thrombotic and haemorrhagic disorders

    British Journal of Haematology, Vol. 125, Núm. 5, pp. 621-628

2003

  1. Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: New application for a classical method

    Journal of Laboratory and Clinical Medicine, Vol. 142, Núm. 5, pp. 298-305

  2. Molecular, ultrastructural and functional characterization of a Spanish family with Hermansky-Pudlak syndrome: Role of insC974 in platelet function and clinical relevance

    British Journal of Haematology, Vol. 123, Núm. 1, pp. 132-138

  3. Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction

    American Journal of Cardiology, Vol. 91, Núm. 10, pp. 1242-1245

  4. The -1C>T mutation in the annexin A5 gene does not affect plasma levels of annexin A5 [2] (multiple letters)

    Blood

2002

  1. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

    Blood, Vol. 100, Núm. 6, pp. 2081-2086

  2. Platelet aggregation through prothrombinase activation induced by non-aggregant doses of platelet agonists

    Blood Coagulation and Fibrinolysis, Vol. 13, Núm. 2, pp. 95-103

2001

  1. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation

    Thrombosis and Haemostasis, Vol. 85, Núm. 4, pp. 686-693

  2. Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease

    British Journal of Haematology, Vol. 115, Núm. 4, pp. 969-976

2000

  1. A common polymorphism flanking the ATG initiator codon of GPIbα does not affect expression and is not a major risk factor for arterial thrombosis

    Thrombosis and Haemostasis, Vol. 83, Núm. 1, pp. 23-28

  2. Evaluation of leukocyte-depleted platelet concentrates obtained by in- line filtration

    Vox Sanguinis, Vol. 78, Núm. 4, pp. 235-241

  3. Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: Impact of filtration timing

    Transfusion, Vol. 40, Núm. 7, pp. 781-788

  4. Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage

    Hematology Journal, Vol. 1, Núm. 4, pp. 269-273

  5. Platelet GP Ib/IX/V complex: Physiological role

    Journal of Physiology and Biochemistry, Vol. 56, Núm. 4, pp. 355-365

  6. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism

    Haematologica, Vol. 85, Núm. 3, pp. 293-297